Preventing catheter-related bloodstream infections related to I.V. connectors
The author provides an overview of the issue and suggests some solutions.
Infection Prevention
FDA approves Levaquin for plague
On April 27, the U.S. Food and Drug Administration approved Levaquin (levofloxacin) to treat patients with plague. The drug was approved under the agency’s…
Asthmatic teenager lands in the ICU
Alarming findings signal the need for noninvasive positive-pressure ventilation.
FDA approves new imaging agent to help identify AD
A study of hospital-acquired infections (HAIs) in the ICU presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases found that inpatient…
Clinical trials 101
Don’t miss the second in a four-part series on clinical trials written by nurses from the National Cancer Institute at the National Institutes of…
Myasthenia gravis: An update
Learn more about this common disorder of neuromuscular transmission and its affects on patients
C. difficile infections at record high
The Centers for Disease Control and Prevention (CDC) states that C. difficile infections are at an all-time high and are linked to 14,000 deaths…
Preventing urinary tract infections in patients with indwelling catheters
One of The Joint Commission’s 2012 National Patient Safety Goals is preventing urinary tract infections caused by catheters. The author reviews best practices that…
FDA warns of drug interactions between Victrelis and ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitors
On Feb. 7, the U.S. Food and Drug Administration announced that drug interactions between the hepatitis C virus protease inhibitor Victrelis (boceprevir) and certain…
2012 recommended immunization schedules released
Access the 2012 recommended immunization schedules on the website for the Centers for Disease Control and Prevention here.
Preventing catheter-related bloodstream infections related to I.V. connectors
The author provides an overview of the issue and suggests some solutions.
FDA approves Levaquin for plague
On April 27, the U.S. Food and Drug Administration approved Levaquin (levofloxacin) to treat patients with plague. The drug was approved under…
Asthmatic teenager lands in the ICU
Alarming findings signal the need for noninvasive positive-pressure ventilation.
FDA approves new imaging agent to help identify AD
A study of hospital-acquired infections (HAIs) in the ICU presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases found…
Clinical trials 101
Don’t miss the second in a four-part series on clinical trials written by nurses from the National Cancer Institute at the National…
Myasthenia gravis: An update
Learn more about this common disorder of neuromuscular transmission and its affects on patients
C. difficile infections at record high
The Centers for Disease Control and Prevention (CDC) states that C. difficile infections are at an all-time high and are linked to…
Preventing urinary tract infections in patients with indwelling catheters
One of The Joint Commission’s 2012 National Patient Safety Goals is preventing urinary tract infections caused by catheters. The author reviews best…
FDA warns of drug interactions between Victrelis and ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitors
On Feb. 7, the U.S. Food and Drug Administration announced that drug interactions between the hepatitis C virus protease inhibitor Victrelis (boceprevir)…
2012 recommended immunization schedules released
Access the 2012 recommended immunization schedules on the website for the Centers for Disease Control and Prevention here.
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.